Strong Buy
Average AnalystStrong Buy
Top AnalystVery Bullish
Stock Target AdvisorBuy
Average UserUSD 24.34
+0.31 (+1.29%)
N/A
0.23M
USD 45.00(+84.88%)
Based on the Dianthus Therapeutics Inc. stock forecast from 3 analysts, the average analyst target price for Dianthus Therapeutics Inc. is USD 45.00 over the next 12 months. Dianthus Therapeutics Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Dianthus Therapeutics Inc. is Very Bullish, which is based on 2 positive signals and 0 negative signals. At the last closing, Dianthus Therapeutics Inc.’s stock price was USD 24.34. Dianthus Therapeutics Inc.’s stock price has changed by +24.06% over the past week, +4.42% over the past month and -3.14% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.